156 related articles for article (PubMed ID: 36528954)
21. Burden of lung cancer and predicted costs of occupational exposure to hexavalent chromium in the EU - The impact of different occupational exposure limits.
Chen-Xu J; Jakobsen LS; Pires SM; Viegas S
Environ Res; 2023 Jul; 228():115797. PubMed ID: 37001847
[TBL] [Abstract][Full Text] [Related]
22. Occupational exposure to Cr(VI) in Finland in 1980-2016 and related lung cancer risk assessment.
Mahiout S; Kiilunen M; Vermeire T; Viegas S; Woutersen M; Santonen T
Regul Toxicol Pharmacol; 2022 Dec; 136():105276. PubMed ID: 36240957
[TBL] [Abstract][Full Text] [Related]
23. Systematic review of biomonitoring data on occupational exposure to hexavalent chromium.
Verdonck J; Duca RC; Galea KS; Iavicoli I; Poels K; Töreyin ZN; Vanoirbeek J; Godderis L
Int J Hyg Environ Health; 2021 Jul; 236():113799. PubMed ID: 34303131
[TBL] [Abstract][Full Text] [Related]
24. Harmonization of Human Biomonitoring Studies in Europe: Characteristics of the HBM4EU-Aligned Studies Participants.
Gilles L; Govarts E; Rodriguez Martin L; Andersson AM; Appenzeller BMR; Barbone F; Castaño A; Coertjens D; Den Hond E; Dzhedzheia V; Eržen I; López ME; Fábelová L; Fillol C; Franken C; Frederiksen H; Gabriel C; Haug LS; Horvat M; Halldórsson TI; Janasik B; Holcer NJ; Kakucs R; Karakitsios S; Katsonouri A; Klánová J; Kold-Jensen T; Kolossa-Gehring M; Konstantinou C; Koponen J; Lignell S; Lindroos AK; Makris KC; Mazej D; Morrens B; Murínová ĽP; Namorado S; Pedraza-Diaz S; Peisker J; Probst-Hensch N; Rambaud L; Rosolen V; Rucic E; Rüther M; Sarigiannis D; Tratnik JS; Standaert A; Stewart L; Szigeti T; Thomsen C; Tolonen H; Eiríksdóttir Á; Van Nieuwenhuyse A; Verheyen VJ; Vlaanderen J; Vogel N; Wasowicz W; Weber T; Zock JP; Sepai O; Schoeters G
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682369
[TBL] [Abstract][Full Text] [Related]
25. HBM4EU results support the Chemicals' Strategy for Sustainability and the Zero-Pollution Action Plan.
Lobo Vicente J; Ganzleben C; Gasol R; Marnane I; Gilles L; Buekers J; Bessems J; Colles A; Gerofke A; David M; Barouki R; Uhl M; Sepai O; Loots I; Crabbé A; Coertjens D; Kolossa-Gehring M; Schoeters G
Int J Hyg Environ Health; 2023 Mar; 248():114111. PubMed ID: 36706581
[TBL] [Abstract][Full Text] [Related]
26. Establishing an occupational exposure limit for hexavalent chromium in the European Union.
Cross HJ; Faux SP; Levy LS
Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 2):S72-6. PubMed ID: 9380839
[TBL] [Abstract][Full Text] [Related]
27. [Human Biomonitoring for Europe (HBM4EU)-first insights into the results of the initiative].
Weise P; Apel P; Kolossa-Gehring M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2022 Sep; 65(9):936-939. PubMed ID: 35997778
[TBL] [Abstract][Full Text] [Related]
28. Development of Policy Relevant Human Biomonitoring Indicators for Chemical Exposure in the European Population.
Buekers J; David M; Koppen G; Bessems J; Scheringer M; Lebret E; Sarigiannis D; Kolossa-Gehring M; Berglund M; Schoeters G; Trier X
Int J Environ Res Public Health; 2018 Sep; 15(10):. PubMed ID: 30248963
[TBL] [Abstract][Full Text] [Related]
29. Human biomonitoring initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) derived for bisphenol A.
Ougier E; Zeman F; Antignac JP; Rousselle C; Lange R; Kolossa-Gehring M; Apel P
Environ Int; 2021 Sep; 154():106563. PubMed ID: 33894553
[TBL] [Abstract][Full Text] [Related]
30. Is Urinary Chromium Specific to Hexavalent Chromium Exposure in the Presence of Co-exposure to Other Chromium Compounds? A Biomonitoring Study in the Electroplating Industry.
Martin Remy A; Robert A; Jacoby N; Wild P
Ann Work Expo Health; 2021 Apr; 65(3):332-345. PubMed ID: 33599259
[TBL] [Abstract][Full Text] [Related]
31. Biomarkers of effect as determined in human biomonitoring studies on hexavalent chromium and cadmium in the period 2008-2020.
Ventura C; Gomes BC; Oberemm A; Louro H; Huuskonen P; Mustieles V; Fernández MF; Ndaw S; Mengelers M; Luijten M; Gundacker C; Silva MJ
Environ Res; 2021 Jun; 197():110998. PubMed ID: 33713715
[TBL] [Abstract][Full Text] [Related]
32. The European Human Biomonitoring Initiative (HBM4EU): Human biomonitoring guidance values (HBM-GVs) for the aprotic solvents N-methyl-2-pyrrolidone (NMP) and N-ethyl-2-pyrrolidone (NEP).
David M; Gerofke A; Lange R; Kolossa-Gehring M; Apel P
Int J Hyg Environ Health; 2021 Sep; 238():113856. PubMed ID: 34619432
[TBL] [Abstract][Full Text] [Related]
33. Occupational exposure to chrome VI compounds in French companies: results of a national campaign to measure exposure (2010-2013).
Vincent R; Gillet M; Goutet P; Guichard C; Hédouin-Langlet C; Frocaut AM; Lambert P; Leray F; Mardelle P; Dorotte M; Rousset D
Ann Occup Hyg; 2015 Jan; 59(1):41-51. PubMed ID: 25381441
[TBL] [Abstract][Full Text] [Related]
34. [New perspectives in biomonitoring of metallic elements: the example of hexavalent chromium].
Mutti A; De Palma G; Goldoni M
G Ital Med Lav Ergon; 2012; 34(3):251-4. PubMed ID: 23213798
[TBL] [Abstract][Full Text] [Related]
35. HBM4EU Occupational Biomonitoring Study on e-Waste-Study Protocol.
Scheepers PTJ; Duca RC; Galea KS; Godderis L; Hardy E; Knudsen LE; Leese E; Louro H; Mahiout S; Ndaw S; Poels K; Porras SP; Silva MJ; Tavares AM; Verdonck J; Viegas S; Santonen T; Hbm Eu E-Waste Study Team
Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948598
[TBL] [Abstract][Full Text] [Related]
36. A comparison of REACH-derived no-effect levels for workers with EU indicative occupational exposure limit values and national limit values in Finland.
Tynkkynen S; Santonen T; Stockmann-Juvala H
Ann Occup Hyg; 2015 May; 59(4):401-15. PubMed ID: 25638729
[TBL] [Abstract][Full Text] [Related]
37. Chromium released from leather - II: the importance of environmental parameters.
Mathiason F; Lidén C; Hedberg YS
Contact Dermatitis; 2015 May; 72(5):275-85. PubMed ID: 25630767
[TBL] [Abstract][Full Text] [Related]
38. Mixture risk assessment and human biomonitoring: Lessons learnt from HBM4EU.
Luijten M; Vlaanderen J; Kortenkamp A; Antignac JP; Barouki R; Bil W; van den Brand A; den Braver-Sewradj S; van Klaveren J; Mengelers M; Ottenbros I; Rantakokko P; Kolossa-Gehring M; Lebret E
Int J Hyg Environ Health; 2023 Apr; 249():114135. PubMed ID: 36758443
[TBL] [Abstract][Full Text] [Related]
39. HBM4EU combines and harmonises human biomonitoring data across the EU, building on existing capacity - The HBM4EU survey.
Gilles L; Govarts E; Rambaud L; Vogel N; Castaño A; Esteban López M; Rodriguez Martin L; Koppen G; Remy S; Vrijheid M; Montazeri P; Birks L; Sepai O; Stewart L; Fiddicke U; Loots I; Knudsen LE; Kolossa-Gehring M; Schoeters G
Int J Hyg Environ Health; 2021 Aug; 237():113809. PubMed ID: 34455198
[TBL] [Abstract][Full Text] [Related]
40. Health Risk Assessment of Occupational Exposure to Hexavalent Chromium in Iranian Workplaces: a Meta-analysis Study.
Nasirzadeh N; Mohammadian Y; Dehgan G
Biol Trace Elem Res; 2022 Apr; 200(4):1551-1560. PubMed ID: 34420136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
